أعرض في EDS

995P Effectiveness of combination of osimertinib with another targeted therapy in advanced EGFR mutated non-small cell lung cancer harbouring other oncogenic drivers: The real-world COMPOSIT study

التفاصيل البيبلوغرافية
العنوان: 995P Effectiveness of combination of osimertinib with another targeted therapy in advanced EGFR mutated non-small cell lung cancer harbouring other oncogenic drivers: The real-world COMPOSIT study
المؤلفون: C. Mehlman, A. Swalduz, I. Monnet, C. Morin, F. Guisier, H. Curcio, P. Du Rusquec, A. Cortot, V. Gounant, B. Abbar, B. Duchemann, E. Giroux-Leprieur, T. Pierret, F.M. Quilot, J. Cadranel, V. Fallet
المصدر: Annals of Oncology. 33:S1008
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Oncology, Hematology
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c93876d39af434e251d2f8dad6f6aab4
https://doi.org/10.1016/j.annonc.2022.07.1121
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........c93876d39af434e251d2f8dad6f6aab4
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534